These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 2575491
1. Disposition and pharmacokinetics of naltrexone after intravenous and oral administration in rhesus monkeys. Reuning RH, Ashcraft SB, Wiley JN, Morrison BE. Drug Metab Dispos; 1989; 17(6):583-9. PubMed ID: 2575491 [Abstract] [Full Text] [Related]
3. The metabolism of naltrexone in man. Wall ME, Brine DR, Perez-Reyes M. NIDA Res Monogr; 1981; 28():105-31. PubMed ID: 6790999 [Abstract] [Full Text] [Related]
4. The urinary excretion profiles of naltrexone in man, monkey, rabbit, and rat. Dayton HE, Inturrisi CE. Drug Metab Dispos; 1976; 4(5):474-8. PubMed ID: 10147 [Abstract] [Full Text] [Related]
12. Influence of a purified diet and route of administration on the metabolism and disposition of estradiol in B6C3F1 mice. Fullerton FR, Greenman DL, Young JF. Drug Metab Dispos; 1987 Mar; 15(5):602-7. PubMed ID: 2891474 [Abstract] [Full Text] [Related]
13. The seminal excretion, plasma elimination, tissue distribution and metabolism of naltrexone in the rabbit. Taylor SM, Rodgers RM, Lynn RK, Gerber N. J Pharmacol Exp Ther; 1980 May; 213(2):289-99. PubMed ID: 7365688 [Abstract] [Full Text] [Related]
14. Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in the dog. Shukla UA, Marathe PH, Pittman KA, Barbhaiya RH. Drug Metab Dispos; 1993 May; 21(3):502-7. PubMed ID: 8100508 [Abstract] [Full Text] [Related]
16. Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexol. Malspeis L, Bathala MS, Ludden TM, Bhat HB, Frank SG, Sokoloski TD, Morrison BE, Reuning RH. Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):43-65. PubMed ID: 810832 [Abstract] [Full Text] [Related]
17. Transfer of naltrexone and its metabolite 6,beta-naltrexol into human milk. Chan CF, Page-Sharp M, Kristensen JH, O'Neil G, Ilett KF. J Hum Lact; 2004 Aug; 20(3):322-6. PubMed ID: 15296587 [Abstract] [Full Text] [Related]
18. Quantitative determination of the urinary excretion of ketobemidone and four of its metabolites after intravenous and oral administration in man. Bondesson U, Hartvig P, Danielsson B. Drug Metab Dispos; 1981 Aug; 9(4):376-80. PubMed ID: 6114838 [Abstract] [Full Text] [Related]
19. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys. Vincent SH, Painter SK, Krieter PA, Colletti AE, Lyszack E, Rosegay A, Dean D, Luffer-Atlas D, Miller RR, Cioffe C, Chiu SH. Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144 [Abstract] [Full Text] [Related]
20. Quantitative determination of naltrexone, 6 beta-naltrexol and 2-hydroxy-3-methoxy-6 beta-naltrexol (HMN) in human plasma, red blood cells, saliva and urine by gas liquid chromatography. Verebey K. NIDA Res Monogr; 1981 Dec; 28():36-51. PubMed ID: 6791012 [Abstract] [Full Text] [Related] Page: [Next] [New Search]